Effectiveness of Lomustine Combined With Bevacizumab in Glioblastoma: A Meta-Analysis

Introduction: Despite surgical and chemotherapeutical treatment options, the prognosis for glioblastoma (GBM) remains poor. Some studies have found that using lomustine plus bevacizumab to treat GBM can prolong overall survival (OS) and progression-free survival (PFS). The aim of this study was to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Xing, Ai, Di, Li, Tong, Xia, Lei, Sun, Lingzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855027/
https://www.ncbi.nlm.nih.gov/pubmed/33551965
http://dx.doi.org/10.3389/fneur.2020.603947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855027/
https://www.ncbi.nlm.nih.gov/pubmed/33551965
http://dx.doi.org/10.3389/fneur.2020.603947

Ejemplares similares